The global market for
healthcare nanotechnology is expected to reach USD 196.02 billion by 2020
growing at a CAGR of 12.1%, according to a new study by Grand View Research,
Inc. Increasing susceptibility of patients towards chronic diseases such as
cardiovascular, neurological, oncology and respiratory diseases coupled with
increasing R&D spending opening new application avenues is expected to
drive market growth over the next six years. Other drivers of this market
include increasing government and private sector R&D aid and new players
entering the market to bridge the gap between supply and demand.
Clinical oncology
nanotechnology applications dominated the overall market in 2013, accounting
for 35% of total market revenue. Higher efficacy of nanomaterials and the
ability of engineered nanoparticles to cross through the blood brain barrier
provides platform for groundbreaking innovations through R&D in the field
of cancer therapy and serves this market as a high impact rendering driver.
To request a
sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology
http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology
Further key findings from the study suggest:
- North America was the largest regional market in 2013, accounting for over 38% of global revenue on account of the extensive investments in research and development of innovative cancer therapies.
- Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020. Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
- Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.
See More
Reports of This Category:
About
Grand View Research:
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
sales@grandviewresearch.com
Web:
www.grandviewresearch.com
No comments:
Post a Comment